Laloglu E., and Alay H. “Endocan As a Potential Marker in Diagnosis and Predicting Disease Severity in COVID-19 Patients: A Promising Biomarker for Patients With False-Negative RT-PCR”. Upsala Journal of Medical Sciences, vol. 127, no. 1, Jan. 2022, doi:10.48101/ujms.v127.8211.